michigan glp-1 gastrointestinal obstruction lawsuit Lawsuits: What to Know as a Prescriber glp-1 bowel obstruction lawsuit in
Description
the choice depends on clinical fit, budget, and provider recommendation
The proportion of patients who had ongoing treatment, regardless of previous discontinuation episodes, ranged between approximately 70% and 80% for both drugs during a 15 year period after treatment initiation across analyses using various grace periods
Georgiadi A, Lichtenstein L, Degenhardt T, Boekschoten MV, van Bilsen M, Desvergne B, et al
[DOI] [PubMed] [Google Scholar] 110.Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
"Death as a Foodborne Illness Curable by Veganism"
A more recent study showed that those who stopped treatment with Mounjaro (another GLP-1 drug) similarly regained around 60% of their lost weight
